Rockwell Medical, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 54.73M59.55M48.97M49.84M52.38M54.19M55.35M53.28M57.30M63.39M61.30M62.20M61.93M72.81M83.61M101.49M
Cost of Revenue 46.84M49.69M43.32M43.15M45.72M45.64M46.41M46.53M53.60M64.97M58.46M59.47M64.35M68.73M74.91M84.00M
Gross Profit 7.89M9.86M5.64M6.69M6.66M8.55M8.94M6.75M3.70M-1.58M2.84M2.73M-2.42M4.08M8.70M17.48M
Operating items
Research & Development 6.45M3.42M17.81M48.27M39.38M7.78M4.96M5.84M6.32M5.64M6.90M7.10M6.83M3.12M1.11M0.02M
Selling, General & Administrative 6.91M9.31M9.52M12.68M14.34M18.32M19.08M21.12M23.30M22.08M21.00M16.18M15.35M15.64M12.14M14.11M
Restructuring Costs 1.03M0.43M
Other Operating Expenses 0.04M0.02M
Operating Expenses 13.37M12.73M27.33M60.96M53.72M26.10M24.04M26.96M29.62M28.75M28.33M23.28M22.18M18.76M13.25M14.13M
Operating Income -5.48M-2.87M-21.68M-54.26M-47.06M-17.56M-15.10M-20.21M-25.92M-32.44M-34.52M-28.42M-30.34M-16.78M-6.67M0.61M
EBIT -5.48M-2.87M-21.68M-54.26M-47.06M-17.56M-15.10M-20.21M-25.92M-32.44M-34.52M-28.42M-30.34M-16.78M-6.67M0.61M
Non-operating items
Interest & Investment Income 0.01M0.20M0.24M0.24M0.10M0.39M0.68M0.81M892.000.39M0.24M0.02M0.03M0.21M0.09M
Other Non Operating Income 0.00M0.31M0.40M-2.47M-2.34M-1.90M-1.77M-1.09M
Non Operating Income 0.40M0.00M0.31M0.40M-2.47M-2.34M-1.90M-1.77M-1.09M
Net income details
EBT -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.40M-25.92M-32.44M-34.16M-30.06M-32.67M-18.68M-8.76M-0.55M
Tax Provisions 0.00M0.40M
Profit After Tax -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.80M-25.92M-32.13M-34.13M-30.89M-32.67M-18.68M-8.44M-0.48M
Income from Continuing Operations -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.80M-25.92M-32.44M-34.16M-30.06M-32.67M-18.68M-8.76M-0.55M
Consolidated Net Income -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.80M-25.92M-32.44M-34.16M-30.06M-32.67M-18.68M-8.76M-0.55M
Income towards Parent Company -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.80M-25.92M-32.44M-34.16M-30.06M-32.67M-18.68M-8.76M-0.55M
Net Income towards Common Stockholders -5.50M-2.68M-21.44M-54.02M-48.78M-21.33M-14.42M-19.80M-25.92M-32.44M-34.16M-30.06M-32.67M-18.68M-8.76M-0.55M
Additional items
EPS (Basic) -0.37-0.16-1.21-2.65-1.48-0.52-0.29-0.39-0.51-0.61-0.56-0.41-3.83-1.31-0.37-0.03
EPS (Weighted Average and Diluted) -0.52-0.29-0.39-0.51-0.41-3.83-1.31-0.37-0.03
Shares Outstanding (Weighted Average) 1.55M1.59M1.88M1.94M3.64M3.96M4.64M4.68M4.71M5.18M5.81M8.51M8.54M11.63M28.49M32.32M
Shares Outstanding (Diluted Average) 75.62M8.53M14.30M23.32M31.06M
EBITDA -5.48M-2.87M-21.68M-54.26M-47.06M-17.56M-15.10M-20.21M-25.92M-32.44M-34.52M-28.42M-30.34M-16.78M-6.67M0.61M
Interest Expenses 0.03M0.01M0.03M1.88M2.36M1.94M2.30M1.25M